Business Context and Reporting Period
This Form 8-K filing by Progyny, Inc. (PGNY) was submitted on April 11, 2025, reporting an event that occurred on April 9, 2025. The filing addresses corporate governance changes regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
Dr. Fred E. Cohen has notified the Board of Directors of his decision not to stand for reelection at the Company's 2025 Annual Meeting of Stockholders. The filing explicitly states that this decision is not related to any disagreement with the Company regarding its operations, policies, or practices. Dr. Cohen will continue to serve as a director until the conclusion of his current term at the Annual Meeting.
Guidance, Outlook, and Risks
The filing contains no management commentary on financial guidance, future outlook, or specific risks. The only contingency noted is the scheduled departure of a director, which is described as a non-contentious decision.
Key Facts for Investors to Verify
- Confirm the date of the 2025 Annual Meeting of Stockholders to determine the exact end date of Dr. Cohen's term.
- Verify if the Board has initiated a search for a replacement director to fill the vacancy upon Dr. Cohen's departure.
- Review subsequent filings to ensure no undisclosed disagreements or operational issues are linked to the director's departure.